Alan Davison

19.5k total citations · 2 hit papers
359 papers, 14.7k citations indexed

About

Alan Davison is a scholar working on Organic Chemistry, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alan Davison has authored 359 papers receiving a total of 14.7k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Organic Chemistry, 85 papers in Molecular Biology and 82 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alan Davison's work include Radiopharmaceutical Chemistry and Applications (70 papers), Lanthanide and Transition Metal Complexes (43 papers) and Organometallic Complex Synthesis and Catalysis (37 papers). Alan Davison is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (70 papers), Lanthanide and Transition Metal Complexes (43 papers) and Organometallic Complex Synthesis and Catalysis (37 papers). Alan Davison collaborates with scholars based in United Kingdom, United States and Canada. Alan Davison's co-authors include Alun G. Jones, M. L. Cuzner, Pamela White, D. M. Bowen, David M. Bowen, Carolyn Beebe Smith, Neil R. Sims, Naren L. Banik, L. K. Kaczmarek and R. H. Holm and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Alan Davison

356 papers receiving 13.5k citations

Hit Papers

NEUROTRANSMITTER-RELATED ... 1971 2026 1989 2007 1976 1971 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Alan Davison 3.9k 3.2k 2.6k 2.6k 2.4k 359 14.7k
Bengt Långström 4.3k 1.1× 2.1k 0.7× 3.5k 1.4× 5.4k 2.1× 3.7k 1.5× 636 21.2k
Tetsuo Nagano 10.5k 2.7× 4.7k 1.5× 4.1k 1.6× 788 0.3× 2.2k 0.9× 378 34.6k
Kazuya Kikuchi 5.5k 1.4× 2.1k 0.7× 2.3k 0.9× 956 0.4× 1.0k 0.4× 242 17.0k
Yasuteru Urano 9.4k 2.4× 3.8k 1.2× 2.1k 0.8× 963 0.4× 1.5k 0.6× 356 29.8k
John A. Katzenellenbogen 12.0k 3.1× 7.5k 2.3× 920 0.4× 4.9k 1.9× 1.2k 0.5× 629 33.8k
Victor J. Hruby 19.5k 5.1× 6.7k 2.1× 4.1k 1.6× 2.0k 0.8× 9.3k 3.8× 858 32.2k
Carl‐Gunnar Swahn 2.1k 0.5× 2.8k 0.9× 193 0.1× 1000 0.4× 1.3k 0.5× 567 9.9k
David A. Brown 5.0k 1.3× 1.0k 0.3× 4.0k 1.5× 322 0.1× 1.4k 0.6× 363 14.7k
Luigi Casella 2.4k 0.6× 1.8k 0.6× 1.0k 0.4× 255 0.1× 653 0.3× 255 9.0k
Alan P. Kozikowski 12.4k 3.2× 9.1k 2.9× 1.1k 0.4× 1.5k 0.6× 3.0k 1.3× 567 23.3k

Countries citing papers authored by Alan Davison

Since Specialization
Citations

This map shows the geographic impact of Alan Davison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Davison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Davison more than expected).

Fields of papers citing papers by Alan Davison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Davison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Davison. The network helps show where Alan Davison may publish in the future.

Co-authorship network of co-authors of Alan Davison

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Davison. A scholar is included among the top collaborators of Alan Davison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Davison. Alan Davison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahmood, Ashfaq, et al.. (2010). The synthesis and structural characterization of the technetium nitrosyl complexes [TcCl(NO)(SC5H4N)(PPh3)2] and [Tc(NO)(SC5H4N)2(PPh3)]. Inorganica Chimica Acta. 365(1). 484–486. 7 indexed citations
2.
Kronauge, James F., et al.. (1998). Uptake of cationic technetium complexes in cultured human carcinoma cells and human xenografts. Nuclear Medicine and Biology. 25(7). 667–673. 10 indexed citations
3.
Madras, Bertha K., Alun G. Jones, Ashfaq Mahmood, et al.. (1996). Technepine: A high-affinity99mtechnetium probe to label the dopamine transporter in brain by SPECT imaging. Synapse. 22(3). 239–246. 53 indexed citations
4.
Mahmood, Ashfaq, et al.. (1996). A new approach to labeling cells with technetium-99m, part I. Preparation of modified polylysine and in vitro cell labeling. Nuclear Medicine and Biology. 23(1). 79–85. 2 indexed citations
5.
Kronauge, James F., et al.. (1994). In vivo metabolism of the technetium isonitrile complex [Tc(2-ethoxy-2-methyl-1-isocyanopropane)6]+. Nuclear Medicine and Biology. 21(4). 583–591. 15 indexed citations
7.
Davison, Alan. (1992). The relevance of experimental allergic encephalomyelitis to multiple sclerosis. Journal of the Royal Society of Medicine. 85(7). 425–426. 2 indexed citations
8.
Kronauge, James F., Mark L. Chiu, Alan Davison, et al.. (1992). Comparison of neutral and cationic myocardial perfusion agents: Characteristics of accumulation in cultured cells. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 19(2). 141–148. 22 indexed citations
9.
Baker, David & Alan Davison. (1991). Mechanisms of immune-mediated demyelinating disease of the central nervous system. Neurochemical Research. 16(9). 1067–1072. 6 indexed citations
10.
Davison, Alan. (1991). Myelin Structure and Demyelination in Multiple Sclerosis. Annals of the New York Academy of Sciences. 633(1). 174–177. 1 indexed citations
11.
Najbauer, József, et al.. (1988). An In Vitro Micromethod for the Quantitative Assessment of Central Demyelination. Journal of Neurochemistry. 50(5). 1469–1477. 9 indexed citations
12.
Davison, Alan, et al.. (1988). Nervous and immune system disorders in multiple sclerosis. Brain Behavior and Immunity. 2(4). 335–340. 1 indexed citations
13.
Carroll, Timothy R., Alan Davison, & Alun G. Jones. (1988). Functional cholesteryl binding agents: Evaluation of viability and specificity of antibodies bound to modified phospholipid vesicles. Biochemical and Biophysical Research Communications. 151(2). 932–938. 1 indexed citations
14.
Jones, Alun G., Michael J. Abrams, Alan Davison, et al.. (1984). Biological studies of a new class of technetium complexes: the hexakis(alkylisonitrile)technetium(I) cations. International Journal of Nuclear Medicine and Biology. 11(3-4). 225–234. 155 indexed citations
15.
Davison, Alan, M. L. Cuzner, & Northern Ireland. (1980). The Suppression of experimental allergic encephalomyelitis and multiple sclerosis. Academic Press eBooks. 25 indexed citations
16.
Davison, Alan & M. L. Cuzner. (1977). IMMUNOCHEMISTRY AND BIOCHEMISTRY OF MYELIN. British Medical Bulletin. 33(1). 60–66. 24 indexed citations
17.
Davison, Alan. (1972). Metabolism of myelin lipids in the developing brain. Biochemical Journal. 128(1). 68P–68P. 4 indexed citations
18.
Paoletti, Rodolfo & Alan Davison. (1971). Chemistry and Brain Development. Advances in experimental medicine and biology. 37 indexed citations
19.
Banik, Naren L. & Alan Davison. (1969). Enzyme activity and composition of myelin and subcellular fractions in the developing rat brain. Biochemical Journal. 115(5). 1051–1062. 177 indexed citations
20.
Davison, Alan & John Dobbing. (1958). RELATIVE STABILITY OF BRAIN LIPIDS. The Lancet. 272(7057). 1158–1159. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026